Unfolding the Future of Alzheimer's Disease: What Primary Care Physicians Should Know

What does the future of Alzheimer's disease management hold? Drs Farlow, Culpepper, van der Flier, and Dubois discuss emerging changes in diagnosis and treatment.The goal of this activity is that learners will be better able to discuss new developments in the recognition and management of Alzheimer's disease (AD). 

Target Audience

This activity is intended for internal medicine physicians, family medicine physicians, geriatricians, Alzheimer's disease (AD) specialists, neurologists, nurse practitioners, and physician assistants caring for patients with AD.

Learning Objectives

 

  • Have increased knowledge regarding the
    • Pathological clinical continuum of AD
    • Recent advances in diagnostic strategies for AD
    • Latest data on emerging therapies for AD

Additional Information

Partner: 
Medscape
Course summary
Available credit: 
  • 0.50 MOC
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.25 Contact hours
Course opens: 
05/09/2022
Course expires: 
05/09/2023
Rating: 
0

Martin R. Farlow, MD

Professor of Neurology
Indiana University School of Medicine
Indianapolis, Indiana, United States 

Larry Culpepper, MD, MPH

Professor of Family Medicine
Boston University School of Medicine
Boston, Massachusetts, United States

Wiesje M. van der Flier, PhD

Scientific Director
Alzheimer Center Amsterdam
Amsterdam UMC
Amsterdam, The Netherlands

Bruno Dubois, MD

Professor of Medicine
Sorbonne University
Paris, France

Disclosure

  • Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Available Credit

  • 0.50 MOC
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC
  • 0.25 Contact hours
Please login or register to take this course.

This course is offered through Medscape. 

To take this course you will be redirected to Medscape's website. You must login or create an account with Medscape in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!